RecruitingNCT06373328

Post Pandemic Pneumococcal Carriage Among Children and Adults

Post-Pandemic Genomic Epidemiology of Pneumococcal Carriage Among Children and Adults in the General US Population


Sponsor

University of Central Florida

Enrollment

900 participants

Start Date

Jun 12, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The PI propose to conduct a genomic epidemiology study of pneumococcal carriage among children and adults in a large metropolitan city. These data will allow PI to assess the post-pandemic population structure, investigate the phylogenetic relationship between isolates from children and adults, and compare pneumococcal populations across diverse geographic areas.


Eligibility

Min Age: 7 Months

Inclusion Criteria5

  • Children, ages 7 to 59 months (less than 5 years)
  • Adults, ages 50 and older
  • Ability to provide informed consent (from parents for children participants)
  • ability to read and speak in English
  • Agree to comply with study procedures (complete online data questionnaire and provide a nasopharyngeal collection).

Exclusion Criteria4

  • Have been on an antibiotic in the last 2 weeks
  • Have a respiratory infection that would make an nasopharyngeal collection improbable
  • Have underlying developmental or chronic conditions impacting immune or respiratory function (e.g., immunocompromised, cystic fibrosis, cerebral palsy, paralysis)
  • Adults unable to consent, individuals who are not yet adults, and prisoners will be excluded from this study.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Central Florida

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06373328


Related Trials